Last Updated on July 16, 2026 by Dr. Bhagat
JOURNAL METRICS·Updated June 2026
Nature Reviews Neurology Impact Factor 2025 (32.6): Neurology Review Journal Metrics & Analysis
Nature Reviews Neurology Impact Factor 2025 reaches 32.6 (Q1, Neurosciences, Science Citation Index Expanded (SCIE)). Launched by Springer Nature in 2005, this journal has rapidly become essential reading for neurologists and neuroscience researchers worldwide.
JOURNAL ORIGINSFrom Launch to 32.6 — The Rise of Nature Reviews Neurology
In the two decades since its founding in 2005, Nature Reviews Neurology has carved out a distinctive niche at the intersection of clinical neurology and basic neuroscience. While many neurology journals skew heavily toward either bench research or bedside practice, Nature Reviews Neurology has pursued a deliberate hybrid strategy: publishing review articles that are scientifically rigorous enough for academic researchers yet clinically relevant enough for practicing neurologists. This dual appeal is a major reason why the journal has achieved an impact factor of 32.6 in the 2025 JCR release.
The journal’s publisher, Springer Nature, has provided Nature Reviews Neurology with the editorial infrastructure and global distribution network necessary to compete against long-established neurology titles. With an ISSN of 1759-4758, the journal publishes monthly, ensuring a steady stream of high-impact reviews that keep the clinical neurology community abreast of transformative developments.
METRICS BREAKDOWNUnpacking the Numbers
The impact factor of 32.6 places Nature Reviews Neurology firmly in the upper tier of neuroscience publications. To understand what this number means in practice, consider that it represents the average number of citations received by each article published in the journal during the two-year calculation window. In a field where review articles typically generate 3-5 times as many citations as original research papers, Nature Reviews Neurology’s focus on commissioned reviews provides a natural advantage — but one that the journal has clearly maximized through editorial excellence.
The Scopus-derived CiteScore of 38.5 provides valuable cross-validation. Because CiteScore uses a four-year citation window rather than the impact factor’s two-year window, the fact that Nature Reviews Neurology achieves 38.5 on this metric suggests that its articles continue to attract citations well beyond the initial post-publication period. This enduring relevance is especially important in neurology, where clinical translation timelines can stretch across many years.
| Metric | Value | Source |
|---|---|---|
| Impact Factor | 32.6 | JCR 2025 (Clarivate) |
| JCR Quartile | Q1 | JCR 2025 |
| CiteScore | 38.5 | Scopus 2025 |
| SJR | 9.8 | Scimago 2025 |
| H-Index | 165 | Google Scholar |
| Subject Category | Neurosciences | Clarivate JCR |
| Publisher | Springer Nature | — |
| ISSN | 1759-4758 | ISSN Portal |
| Established | 2005 | — |
| Publication Frequency | Monthly | Publisher |
Key Takeaways
- IF 2025: 32.6 positions Nature Reviews Neurology among the top neurology review journals globally
- Q1 ranking: Q1 in Neurosciences per Clarivate JCR 2025
- CiteScore 38.5: Confirms sustained citation performance across a 4-year window
- SJR 9.8: Citations come from high-prestige journals, indicating trusted authority
- H-index 165: Substantial body of highly cited review articles
CLINICAL RELEVANCEWhy Neurologists Trust Nature Reviews Neurology
In a medical specialty where treatment decisions can have life-altering consequences, the quality of information matters enormously. Nature Reviews Neurology addresses this need by publishing reviews that bridge the gap between emerging preclinical discoveries and their potential clinical applications. Topics regularly covered include neurodegenerative disease mechanisms, stroke pathophysiology, multiple sclerosis immunology, epilepsy genetics, headache neurobiology, and neuromuscular disorders.
The journal’s editorial team places a premium on articles that offer actionable insights for clinical practice. A review on Alzheimer’s disease published in Nature Reviews Neurology, for example, is expected to not only summarize the latest molecular findings but also contextualize them within the framework of ongoing clinical trials and evolving diagnostic criteria. This clinical orientation distinguishes Nature Reviews Neurology from more basic-science-oriented neuroscience journals and helps explain its broad readership.
SCOPUS & SCHOLAR METRICSThe Broader Bibliometric Picture
The SJR score of 9.8 reveals that Nature Reviews Neurology is cited by some of the most selective journals in medicine and biology. This is significant because it indicates that the journal’s reviews are trusted sources of information even among highly discriminating audiences. The h-index of 165 from Google Scholar further demonstrates that the journal has produced a substantial corpus of papers that have each been cited at least 165 times.
Collectively, these metrics paint a portrait of a journal that is not merely high-impact but also enduringly influential. For a title founded as recently as 2005, this level of bibliometric achievement is remarkable and speaks to the editorial vision that has guided Nature Reviews Neurology from its inception.
AUTHOR GUIDELINESWriting for Nature Reviews Neurology
As a review journal, Nature Reviews Neurology primarily publishes commissioned articles. The editorial team identifies timely topics and invites leading experts to contribute comprehensive reviews. Authors who wish to propose a review topic should contact the editorial office with a clear outline of the proposed scope, its relevance to clinical neurology, and its potential to advance the field.
Successful reviews in Nature Reviews Neurology typically feature clear structural organization, high-quality illustrations that clarify complex concepts, balanced coverage of controversial topics, and explicit discussion of clinical implications. The journal encourages inclusion of expert opinion where evidence is emerging but not yet definitive.
FREQUENTLY ASKED QUESTIONSFAQ About Nature Reviews Neurology
What is the Nature Reviews Neurology impact factor for 2025?
The 2025 impact factor is 32.6, as reported in the Clarivate JCR released in June 2026.
Is Nature Reviews Neurology a Q1 neuroscience journal?
Yes, Nature Reviews Neurology holds a Q1 ranking in the Neurosciences category of the Clarivate JCR 2025.
Who publishes Nature Reviews Neurology and when was it founded?
Nature Reviews Neurology is published by Springer Nature and was established in 2005.
What is the CiteScore of Nature Reviews Neurology?
The CiteScore from Scopus is 38.5.
Does Nature Reviews Neurology accept original research articles?
No, Nature Reviews Neurology publishes commissioned review articles, perspectives, and opinion pieces focused on clinical and translational neurology.
What is the ISSN of Nature Reviews Neurology?
The ISSN is 1759-4758.
How often is Nature Reviews Neurology published?
Nature Reviews Neurology is published monthly.
What neurology topics does Nature Reviews Neurology cover?
The journal covers neurodegeneration, stroke, multiple sclerosis, epilepsy, headache, movement disorders, neuromuscular disease, neuro-oncology, and neuroimmunology, with emphasis on translational and clinical relevance.